Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
5 studies found for:    Familial Periodic Paralyses

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Familial Periodic Paralyses
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results 		Hyper- and Hypokalemic Periodic Paralysis Study
Conditions: Hyperkalemic Periodic Paralysis;   Hypokalemic Periodic Paralysis
Interventions: Drug: Dichlorphenamide (double-blind);   Drug: Placebo (double-blind);   Drug: Dichlorphenamide (open-label)
2 Recruiting Bumetanide in Hypokalaemic Periodic Paralysis
Condition: Hypokalemic Periodic Paralysis
Interventions: Drug: Bumetanide;   Drug: Placebo
3 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Conditions: Paralysis, Hyperkalemic Periodic;   Hypokalemic Periodic Paralysis;   Paramyotonia Congenita
Intervention: Drug: dichlorphenamide
4 Completed Lamotrigine as Treatment of Myotonia
Conditions: Dystrophia Myotonica Type 1;   Myotonia Congenita;   Paramyotonia Congenita;   Hyperkalemic Periodic Paralysis;   Potassium-Aggravated Myotonia
Interventions: Drug: Lamotrigine;   Drug: Placebo
5 Active, not recruiting Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis
Condition: Thyrotoxic Periodic Paralysis
Intervention: Other: No intervention involved
To Top

† Indicates status has not been verified in more than two years